Background: the decision-making process of patients with angiographically-intermediate coronary lesions (ICL) is clinically challenging and may benefit from adjunctive invasive techniques. Fractional-flow-reserve (FFR) represents the gold standard to evaluate ICL but optical-coherence-tomography (OCT) is a novel, promising, high resolution coronary imaging technique. Objectives: 1. Investigate the relation between OCT and FFR parameters in ICL and understand if OCT measures may predict FFR. 2. Understand if OCT parameters may predict clinical outcome of patients with ICL not underwent revascularization on the bases of negative FFR. Study design: multicentre, international, individual patient's level data pooled analysis.
Principal investigators that enrolled stable or unstable patients with ICL who underwent both FFR and OCT assessment of the same lesion, will be contacted to participate the study. Agreeing investigators will be asked to complete a structured database by providing a series of key baseline clinical and angiographic data, OCT and FFR parameters. Collected dataset will include: sex, age, hypertension, diabetes, hypercholesterolemia, current smoking, family history of CAD, clinical presentation, previous PCI, previous MI, previous CABG, non-invasive ischemia, angina, n° of diseased vessels, diseased vessel, percentage diameter stenosis at quantitative coronary angiography (QCA% stenosis), length of stenosis at quantitative coronary angiography, presence of thrombus or ulceration, MLA, area stenosis at OCT, FFR protocol (intracoronary adenosine, endovenous adenosine, contrast) results and long term clinical follow-up.
Study Type
OBSERVATIONAL
Enrollment
500
Lesion OCT assessment
Policlinico A. Gemelli. Università Cattolica del Sacro Cuore
Roma, Italy
OCT measures predicting FFR - mean lumen area
ICL mean lumen area (MLA)
Time frame: 1 day
OCT measure predicting FFR - area stenosis
ICL percentage area stenosis (AS)
Time frame: 1 day
OCT measure predicting FFR - thrombus or ulceration
Presence of thrombus or ulceration at the level of ICL
Time frame: 1 day
Major Adverse Cardiac Events (MACE) in untreated patients (no PCI or CABG)
Major Adverse Cardiac Events (MACE) defined as the composite of: * cardiac death (any death not clearly attributed to non cardiac causes) * (spontaneous) myocardial infarction (MI) * surgical or percutaneous coronary revascularization of the target lesion (PCI o CABG)
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.